题名 | 104-week efficacy and safety of telbivudine based optimization strategy in chronic hepatitis B patients: A randomized, controlled study |
作者 | Jian Sun1, Qing Xie2, Deming Tan3, |
杂志 | Hepatology |
年|卷|期 | DOI: 10.1002/hep.26885 |
页码 | DOI: 10.1002/hep.26885 |
链接 | http://onlinelibrary.wiley.com/doi/10.1002/hep.26885/abstract |
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |